Clinical characteristics and outcomes of patients with acute myocardial Infarction without standard modifiable risk factors (SMuRFs)
European Journal of Internal Medicine · 2025
DOI: 10.1016/j.ejim.2025.07.007 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Internal Medicine, 2025. Verfasst von Dimitrios V Moysidis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Cardiology, Hippokration General Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, …. Hauptthemen laut MEDLINE: Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: The etiology as well as the prevalence of acute myocardial infarction (AMI) in patients without history of standard modifiable risk factors (SMuRFs) remains unclear, especially in European populations. Simultaneously, evidence suggests that SMuRF-less patients may experience worse short-term outcomes after AMI. METHODS: The "Beyond-SMuRFs" prospective observational study (NCT05535582) included 1011 consecutive patients with AMI in Greece, who underwent coronary angiography and had available data on clinical, laboratory and imaging parameters. SMuRF-less patients were defined as those who have no history of diabetes mellitus, dyslipidemia, hypertension or smoking. Multivariable logistic-regression and receiver operating characteristic (ROC) analyses were implemented to investigate potential predictors of SMuRF-less AMIs and their predictive ability. Kaplan-Meier curves and Cox-regresion analyses were used to compare all-cause mortality and the composite outcome of cardiovascular death or/and AMI/heart-failure (HF) re-hospitalization or/and stroke among patients with and without SMuRFs. RESULTS: Of 1011 patients with AMI (mean age 62.0 ± 11.8 years), 842 (83.2 %) had at least on SMuRF and 169 (16.7 %, 95 % CI: 14.5 %-19.1 %) were SMuRF-less patients. When patients with obesity or former smoking status were excluded from the SMuRF-less group, this number decreased to 140 (13.8 %, 95 % CI: 11.7 %-16.1 %). The multivariable logistic regression model showed that positive family history of AMI [adjusted Odds Ratios (aOR): 1.88 [1.26-2.80], p = 0.002), history of rheumatic/inflammatory disorders (3.31 [1.38-7.93], p = 0.007), major psychiatric disease (2.77 [1.24-6.19], p = 0.013) and drugs/alcohol abuse (4.45 [2.24-8.82], p < 0.001) were independently associated with the occurence of SMuRF-less AMI. The ROC area under the curve for this model was 0.64 ([0.58-0.69], p = 0.001) but was increased to 0.78 [0.73-0.83], p = 0.001), when patients with former smoking and obesity were not considered as SMuRF-less. Regarding the short-term (in-hospital and 30-day) outcomes, SMuRF-less patients exhibited higher rates of all-cause death [adjusted Hazard Ratio (aHR): 2.45 [1.36-4.41], p = 0.003 and 2.38 [1.32-4.31], p = 0.003, respectively] and the secondary composite outcome (aHR: 2.99 [1.65-5.09]; p = 0.001 and 2.75 [1.60-4.70]; p = 0.001, respectively). However, at long-term follow-up non-significant differences were observed. CONCLUSIONS: Positive family history, history of inflammatory or major psychiatric diseases, along with drug or alcohol abuse, were independently associated with SMuRF-less AMIs. SMuRF-less patients experienced worse short-term outcomes than patients with SMuRFs, which was not maintained at the long-term follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Department of Cardiology, Hippokration General Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece. Electronic address:…
- First Department of Cardiology, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, St. Kyriakidi 1, 54636, Greece.
- 424 General Military Hospital of Thessaloniki, Greece.
- Department of Emergency Medicine, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, St. Kyriakidi 1, 54636, Greece.
- Third Department of Cardiology, Hippokration General Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
- First Propedeutic Department of Internal Medicine, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, St. Kyriakidi 1, 54636, Greece.
Zitieren
APA
Moysidis, D. V., Anastasiou, V., Daios, S., Papazoglou, A. S., Karagiannidis, E., Fyntanidou, B., Kamperidis, V., Didagelos, M., Konstantinidou, S., Savopoulos, C., Makedou, K., Kyriakidis, P., Giannakoulas, G., Ziakas, A., Giannopoulos, G., & Vassilikos, V. (2025). Clinical characteristics and outcomes of patients with acute myocardial Infarction without standard modifiable risk factors (SMuRFs). European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2025.07.007
Vancouver
Moysidis DV, Anastasiou V, Daios S, Papazoglou AS, Karagiannidis E, Fyntanidou B, et al. Clinical characteristics and outcomes of patients with acute myocardial Infarction without standard modifiable risk factors (SMuRFs). European Journal of Internal Medicine. 2025. doi:10.1016/j.ejim.2025.07.007
BibTeX
@article{Moysidis2025,
author = {Moysidis, Dimitrios V and Anastasiou, Vasileios and Daios, Stylianos and Papazoglou, Andreas S and Karagiannidis, Efstratios and Fyntanidou, Barbara and Kamperidis, Vasileios and Didagelos, Matthaios and Konstantinidou, Sonia and Savopoulos, Christos and Makedou, Kali and Kyriakidis, Panagiotis and Giannakoulas, George and Ziakas, Antonios and Giannopoulos, Georgios and Vassilikos, Vassilios},
title = {Clinical characteristics and outcomes of patients with acute myocardial Infarction without standard modifiable risk factors (SMuRFs)},
journal = {European Journal of Internal Medicine},
year = {2025},
doi = {10.1016/j.ejim.2025.07.007}
}
EUVIMED